Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
, , ,
In the realm of cell-based therapies and antibodydrug conjugates (ADCs), CT041, a CLDN18.2-targeted CAR-T product, is being studied in gastrointestinal cancers (NCT04404595), while enfortumab vedotin, targeting Nectin-4, is under investigation for metastatic castration-resistant prostate cancer (NCT04754191)
Facilities managing large quantities often use labeled shelving systems
It is important to distinguish between scientific interest and established clinical evidence
US$ 24.07
US$ 25.23
US$ 20.00
US$ 28.34
US$ 20.45
US$ 20.77
US$ 25.17
US$ 24.73
US$ 25.15
